Comment From Breakthrough Breast Cancer Re New NICE Guidelines On The Treatment And Care Of People With Early And Advanced Breast Cancer, UK
Main Category: Breast CancerAlso Included In: Cancer / Oncology
Article Date: 24 Feb 2009 - 6:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer, said:
"These new clinical guidelines provide welcome clarity on which treatments and services breast cancer patients should typically receive, according to their needs. All patients should receive the highest standard of care, so it's important that these guidelines are implemented swiftly and consistently. It's also vital that patients are made aware of the guidelines so they are able to make informed decisions about treatment options."
Breakthrough Breast Cancer
Visit our breast cancer section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/140102.php>
APA
http://www.medicalnewstoday.com/releases/140102.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




